~~<i id='F877D7CE14'><strike id='F877D7CE14'><tt id='F877D7CE14'><pre id='F877D7CE14'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：comprehensive 2025-09-06 04:42:07 - browse：6718

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： As obesity drug market grows, telehealth companies court payers

focus

explore

Wikipedia

explore

leisure time

knowledge

AlexHogan/STATWASHINGTON—Anewtroveofinternalemailsandotherdocumentsfromthee-cigarettemakerJuulreveal

WSS

How to make over

Ebola vaccine can save some who are already sick, per new study

Trans patients at the end of life deserve respect and dignity

Congress must protect the remaining independent doctors

Congress considering partial increase for doctor pay in Medicare

Report cites 'urgent' need to recruit more diverse clinical trial participants

hotspot

leisure time

focus

Alkermes shareholders re

People can get long Covid without testing positive for virus: Study

Wildfire smoke exposes gaps in outdoor worker protections

Ebola vaccine can save some who are already sick, per new study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Doctors on social media are being harassed and cyberbullied

Malaria cases in Florida and Texas: Here’s what you need to know

Republicans love RFK Jr. What's that tell us about health in 2024?

The high cost of giving birth even with insurance

Listen: Vivek Ramaswamy's star turn & leaky drug data

explore

Too many hospitalized Covid

Roche's accidental data boosts hopes for anti

Bernie Sanders gets little from pharma CEOs on drug prices

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Wikipedia

explore

leisure time

knowledge